AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ril-Plus Tablet

Prescription Icon
Prescription Required

Marketer

Artus Pharma Pvt Ltd

Salt Composition

Aspirin (150mg) + Clopidogrel (75mg)

Overview Ril-Plus Tablet

DuoPlate-Rx combines two antithrombotic agents to inhibit harmful clot formation within blood vessels. This medication prevents cardiac events (heart attack or stroke) in patients with cardiovascular disease and treats acute coronary syndrome (ACS). Consistent daily intake, with food, at regularly spaced intervals as directed by your physician, is crucial for efficacy. Maintain the prescribed dosage and duration; do not prematurely discontinue treatment. A healthy lifestyle (low-fat diet, exercise, smoking cessation) enhances therapeutic response. Common side effects include dyspepsia, easy bruising, and epistaxis. Increased bleeding risk necessitates caution with sharp objects. Alcohol consumption should generally be avoided. Prior to initiating treatment, inform your physician of any liver or kidney conditions, pregnancy (planned or current), breastfeeding, or other medications being taken, as drug interactions are possible.

Uses of Ril-Plus Tablet

Preventing heart attacks and strokes; managing acute coronary syndrome.

Major Benefits of Ril-Plus Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Ril-Plus Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer Ril-Plus with food.

Common Side effects of Ril-Plus Tablet:

  • Bruise
  • Gastrointestinal bleeding
  • Increased bleeding tendency
  • Nosebleeds

How to use Ril-Plus Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Ril-Plus Tablet with a meal.

How Ril-Plus Tablet works:

Ril-Plus tablets contain aspirin and clopidogrel, two medications that inhibit platelet aggregation. This dual action helps prevent heart attacks by reducing the risk of dangerous blood clot development. The medication is also indicated for the treatment of acute coronary syndrome.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Ril-Plus Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Ril-Plus tablets during pregnancy carries a confirmed risk to the fetus and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Ril-Plus tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Ril-Plus Tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Ril-Plus Tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Ril-Plus Tablets; consult a physician before use.

LiverLiverCAUTION

Patients with liver impairment should use Ril-Plus Tablet cautiously, potentially requiring a modified dosage. Physician consultation is advised. Ril-Plus Tablet is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Ril-Plus Tablet :

Should you forget a Ril-Plus Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ril-Plus Tablet

LabelValue
Potential for Dependence None.
Medication Classification Hematological

FAQs on Ril-Plus Tablet

Ril-Plus Tablet may have been part of your treatment if you experienced a myocardial infarction, underwent coronary artery stent placement, or had coronary artery bypass grafting.
Ril-Plus Tablets function as an anticoagulant, inhibiting platelet aggregation to reduce clot formation. This mechanism helps mitigate the risk of stroke or heart attack in patients with cardiac conditions, those recovering from a myocardial infarction, or experiencing unstable angina.
The prescribed length of Ril-Plus Tablet treatment will be determined by your physician. This decision will factor in your specific condition, the type of stent implanted, and any bleeding episodes encountered during treatment. A typical Ril-Plus Tablet course lasts at least one year. To optimize treatment outcomes, adhere strictly to your doctor's instructions. Never cease taking Ril-Plus Tablet without prior medical consultation; abrupt cessation may heighten the risk of stent thrombosis, heart attack, and even death.
Consuming alcohol alongside Ril-Plus Tablet is discouraged due to an elevated risk of gastrointestinal hemorrhage. This can manifest as hematemesis (vomiting blood, possibly bright red or dark/coffee-ground-like) or melena (bloody or black, tarry stools). Consult your physician if you have any concerns.
Ril-Plus Tablets pose a risk of severe, potentially fatal hemorrhage. Increased bruising and prolonged bleeding, even from minor injuries (such as shaving nicks), are possible. Seek immediate medical care for excessive or persistent bleeding. Report dark, tarry stools or blood in the urine to your physician. Be alert for stroke symptoms including sudden numbness or weakness (unilateral or bilateral), gait difficulty, cognitive impairment, dysarthria, vertigo, and unexplained headache. The occurrence of stroke, while infrequent, necessitates immediate medical intervention due to its life-threatening nature; contact your doctor at once if any such symptoms appear.
Preoperative or pre-treatment cessation of Ril-Plus Tablet will be determined by your physician. Elective procedures may necessitate discontinuation of Ril-Plus Tablet several days (typically seven) prior to the intervention to mitigate the heightened risk of hemorrhage. Independent cessation of Ril-Plus Tablet is inadvisable without prior consultation with your doctor.
Patients with allergies to Ril-Plus Tablet or its components should avoid its use. Ril-Plus Tablet is contraindicated for individuals with a history of severe hepatic impairment, peptic ulcers, cerebral hemorrhage (including stroke or TIA), or hemophilia. Furthermore, Ril-Plus Tablet should not be used by women who are pregnant, attempting pregnancy, or breastfeeding.
Remembered a missed Ril-Plus Tablet dose? Take it immediately. However, if your next dose is nearly due, omit the forgotten dose and proceed with your regular schedule. Never double the dose; doing so could heighten the risk of adverse reactions.
Minimize actions that could lead to bleeding. Exercise caution when shaving or brushing to avoid cuts. Pain relievers should be avoided unless medically necessary. If ibuprofen or similar medication is required for conditions such as joint pain, headache, or backache, consult your physician beforehand. Concomitant use of Ril-Plus Tablet and pain relievers increases the risk of stomach ulcers and bleeding. Excessive alcohol consumption alongside Ril-Plus Tablet should also be avoided due to the increased risk of stomach irritation and ulceration.
Ril-Plus Tablet
23
MRP 28
17% off